Log in to your Inderes Free account to see all free content on this page.
Xbrane Biopharma
8.28 SEK
-0.24 %
Less than 1K followers
XBRANE
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xbrane Biopharma
P/E
Median 2019-2025
EV/S
Median 2022-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 490.31 | 1,059.98 | 1,485.11 | 1,163.43 | 141.71 | 20.10 | 10.20 |
| Shares | 0.8 | 1.3 | 1.7 | 1.9 | 2.1 | 12.2 | 20.6 |
| Market cap | 387.2 | 1,354.9 | 2,540.8 | 2,258.2 | 298.1 | 245.9 | 210.2 |
| Enterprise value | 229.3 | 1,118.0 | 2,290.5 | 2,102.5 | 464.2 | 313.3 | - |
| EV/S | - | - | - | 36.5 | 1.9 | 1.6 | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | neg. | neg. | - |
| EV/EBIT | neg. | neg. | neg. | neg. | neg. | neg. | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | 127.5 |
| P/B | 2.10 | 5.26 | 5.88 | 5.31 | 1.74 | 1.18 | 0.37 |
| P/S | - | - | - | 39.2 | 1.2 | 1.2 | 1.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 54.4 % | 55.6 % | 62.7 % | 61.5 % | 26.2 % | 24.8 % | 83.5 % |
| Gearing ratio | 3.4 % | 2.4 % | 10.4 % | 9.0 % | 135.1 % | 91.9 % | 10.4 % |
Login required
This content is only available for logged in users